{"gene":"ALDH2","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1992,"finding":"The ALDH2*2 allele (Glu487Lys substitution) produces an inactive protein subunit that is unable to metabolize acetaldehyde, leading to acetaldehyde accumulation after alcohol consumption and associated flushing response.","method":"Allele-specific oligonucleotide hybridization of amplified genomic DNA; population genotyping with phenotypic correlation","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across 21 populations, direct genotype-phenotype correlation established","pmids":["1733836"],"is_preprint":false},{"year":2006,"finding":"ALDH2-deficient alcoholics (ALDH2 1/2 genotype) accumulate significantly higher levels of acetaldehyde-derived DNA adducts (N2-ethyl-2'-deoxyguanosine, alpha-S- and alpha-R-methyl-gamma-hydroxy-1,N2-propano-2'-deoxyguanosine) in blood DNA compared to ALDH2 1/1 alcoholics, demonstrating that ALDH2 genotype directly affects acetaldehyde-induced genotoxic damage.","method":"LC/ESI-MS/MS quantification of acetaldehyde-derived DNA adducts in blood DNA from 44 Japanese alcoholic patients stratified by ALDH2 genotype","journal":"Chemical research in toxicology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct biochemical measurement of DNA adducts in human subjects with defined genotype, single lab with rigorous quantitative MS method","pmids":["17040107"],"is_preprint":false},{"year":2009,"finding":"Aldh2 knockout mice are more susceptible to ethanol and acetaldehyde-induced toxicity than wild-type mice, showing increased mortality when fed ethanol and more severe toxic symptoms (weight loss, higher blood acetaldehyde levels) upon acetaldehyde inhalation, confirming ALDH2's essential role in acetaldehyde detoxification in vivo.","method":"Knockout mouse model with ethanol feeding and acetaldehyde inhalation exposure; blood acetaldehyde measurement","journal":"Toxicology mechanisms and methods","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined phenotypic readout, multiple exposure paradigms, replicated across multiple published studies reviewed","pmids":["19874182"],"is_preprint":false},{"year":2015,"finding":"The ALDH2(E487K) knockin mutation causes increased protein turnover and dominant-negative reduction of ALDH2 expression, impaired acetaldehyde clearance, increased sensitivity to alcohol-induced toxicity, increased DNA damage response in hepatocytes, and accelerated hepatocellular carcinoma development after carcinogen treatment, establishing ALDH2 as a tumor suppressor that maintains genomic stability.","method":"Knockin mice with E487K mutation at endogenous Aldh2 locus; carcinogen treatment; DNA damage assays; comparison with human HCC patient tissue","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — physiological knockin model, multiple orthogonal readouts, validated in human patient tissue","pmids":["26150517"],"is_preprint":false},{"year":2015,"finding":"ALDH2 in esophageal keratinocytes protects against acetaldehyde-derived DNA damage (N2-ethylidene-2'-deoxyguanosine adducts): Aldh2-knockout mice show higher DNA adduct levels in esophagus after ethanol consumption; forced ALDH2 overexpression in human keratinocytes sharply reduces adduct levels; acetaldehyde induces ALDH2 expression in both mouse and human esophageal keratinocytes.","method":"Aldh2 knockout mice with ethanol exposure; ALDH2 knockdown and overexpression in human esophageal keratinocytes; DNA adduct quantification","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal genetic approaches (KO, KD, OE) with direct DNA damage readout in both mouse and human cell systems","pmids":["26374466"],"is_preprint":false},{"year":2015,"finding":"4-Hydroxynonenal (4-HNE) impairs ALDH2 activity and reduces mitochondrial respiration in H9C2 cardiomyocytes; ALDH2 inhibition (by DSF or siRNA knockdown) also reduces mitochondrial respiratory reserve capacity and increases cell death, establishing that ALDH2 activity is required for normal mitochondrial function in cardiomyocytes.","method":"4-HNE treatment, disulfiram inhibition, and siRNA knockdown of ALDH2 in H9C2 cells; Seahorse mitochondrial respiration assay; cell viability assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple inhibition methods (chemical + genetic) with functional metabolic readout, single lab","pmids":["26577527"],"is_preprint":false},{"year":2016,"finding":"PKCε phosphorylates and activates ALDH2; PKCε-ALDH2 axis regulates adipogenesis through control of 4-HNE levels and PPARγ signaling. ALDH2 knockdown increases intracellular 4-HNE and attenuates adipocyte differentiation, while ALDH2 activation (Alda-1) or PKCε agonist treatment enhances adipogenesis.","method":"siRNA knockdown of ALDH2 and PKCε in 3T3-L1 preadipocytes; Alda-1 treatment; whole-genome microarray profiling; adipogenesis assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown plus pharmacological activation with gene expression profiling, single lab, multiple methods","pmids":["27575855"],"is_preprint":false},{"year":2016,"finding":"ALDH2 inhibits hepatocellular carcinoma cell migration and invasion by altering redox status through regulation of acetaldehyde levels, which in turn activates the AMP-activated protein kinase (AMPK) signaling pathway; the ALDH2-acetaldehyde-redox-AMPK axis mediates the anti-metastatic function of ALDH2 in HCC.","method":"ALDH2 overexpression and knockdown in HCC cell lines and mouse xenografts; AMPK signaling analysis; migration/invasion assays","journal":"Hepatology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal gain/loss-of-function, in vivo xenograft, pathway validation, single lab","pmids":["28027570"],"is_preprint":false},{"year":2017,"finding":"VHL transcriptionally regulates ALDH2 expression by binding the ALDH2 promoter region (-130 bp to -160 bp) and activating HNF-4α transcription; VHL deficiency reduces ALDH2 expression, and decreased ALDH2 contributes to enhanced anthracycline cytotoxicity in clear cell renal cell carcinoma.","method":"Subtractive proteomics, RNAi/overexpression verification, promoter binding assay, patient tissue correlation in ccRCC","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter binding demonstrated, validated by multiple approaches and human tissue correlation","pmids":["28643803"],"is_preprint":false},{"year":2018,"finding":"Activation of Gi-coupled receptors (histamine H4, adenosine A3, sphingosine-1-phosphate S1P1) in cardiac mast cells sequentially activates PKCε and then ALDH2; increased ALDH2 enzymatic activity inhibits aldehyde-induced mast cell renin release, prevents local cardiac RAS activation, reduces norepinephrine release, and alleviates reperfusion arrhythmias.","method":"Ex vivo ischemia/reperfusion models in guinea pig and mouse hearts; human and murine mast cell lines; pharmacological receptor activation","journal":"Current medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ex vivo functional models with receptor pharmacology, mechanistic pathway defined, single lab","pmids":["29446730"],"is_preprint":false},{"year":2018,"finding":"Chronic pain-induced 4-HNE accumulation causes SIRT1 carbonylative inactivation and impairs LKB1-AMPK interaction, increasing myocardial ischemia/reperfusion susceptibility; cardiac-specific ALDH2 upregulation (via AAV9-cTNT delivery) detoxifies 4-HNE, prevents SIRT1 carbonylation, restores LKB1-AMPK interaction, and reduces MI/R injury.","method":"CCD chronic pain model; ALDH2 KO mice; AAV9-mediated cardiac-specific ALDH2 overexpression; SIRT1 carbonylation assay; LKB1-AMPK co-immunoprecipitation","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and viral delivery approaches, molecular pathway validation including Co-IP, single lab","pmids":["29463997"],"is_preprint":false},{"year":2019,"finding":"ALDH2 deficiency increases 4-HNE accumulation, which activates the 4-HNE/PPARγ/CD36 pathway: ALDH2-deficient macrophages show downregulated PPARγ and CD36 expression, suppressing foam cell formation induced by oxidized LDL (but not acetylated LDL).","method":"ALDH2-deficient and control mouse peritoneal macrophages; ox-LDL and ac-LDL treatment; CD36 inhibitor; Western blot; foam cell assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO macrophages with pharmacological confirmation, pathway validated, single lab","pmids":["30853183"],"is_preprint":false},{"year":2019,"finding":"4-Hydroxynonenal (4-HNE), a lipid peroxidation product not detoxified in ALDH2-deficient conditions, drives pulmonary hypertension by stabilizing HIF-1α and increasing Drp1 (Ser616) phosphorylation, promoting mitochondrial fission and PASMC proliferation; ALDH2 overexpression specifically in pulmonary artery smooth muscle cells (but not endothelial cells) prevents HPH development.","method":"ALDH2 transgenic and KO mice; chronic hypoxia model; AAV-mediated cell-type-specific ALDH2 overexpression (ICAM2p vs. SM22αp); human PASMC in vitro; HIF-1α and Drp1 phosphorylation assays","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific genetic dissection with multiple mouse models and mechanistic pathway validation, multiple orthogonal methods","pmids":["31510791"],"is_preprint":false},{"year":2019,"finding":"ALDH2 repression in lung adenocarcinoma leads to acetaldehyde accumulation, which enhances DNA damage and promotes cell migration; ALDH2 knockdown increases and overexpression decreases proliferation, stemness, and migration of lung adenocarcinoma cells; Aldh2-KO mouse lung tissues show increased acetaldehyde and DNA damage in vivo.","method":"ALDH2 overexpression and knockdown in lung adenocarcinoma cells; Aldh2-KO mice; Alda-1 treatment; DNA damage assays","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal gain/loss-of-function in vitro plus in vivo KO validation, single lab","pmids":["31071657"],"is_preprint":false},{"year":2020,"finding":"ALDH2 inhibition ablates pathological vascular smooth muscle cell (VSMC) phenotypic switch (contractile to synthetic) through interaction with myocardin; ALDH2 deficiency downregulates miR-31-5p (via increased Max expression), which relieves repression of myocardin mRNA, promoting contractile VSMC phenotype and protecting against aortic aneurysm/dissection.","method":"ALDH2 inhibitor treatment in mouse AAD models (BAPN and Ang II); microarray and bioinformatics; gain/loss-of-function for miR-31-5p; primary human VSMC experiments; interaction studies","journal":"European heart journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mouse models, primary human cells, pathway dissection with multiple methods, single lab","pmids":["32428930"],"is_preprint":false},{"year":2020,"finding":"Digenic mutations in ALDH2 (rs671 defective allele) combined with ADH5 mutations cause AMeD syndrome through combined deficiency of formaldehyde clearance, leading to formaldehyde-induced DNA damage that saturates Fanconi anemia repair capacity and impairs hematopoietic stem cell differentiation and proliferation.","method":"Patient genetic analysis; cellular studies in patient-derived cells; Adh5/Aldh2 double-knockout mouse model recapitulating AMeD phenotypes","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — human patient genetics combined with mouse double-KO model and cellular mechanistic studies, multiple orthogonal methods","pmids":["33355142"],"is_preprint":false},{"year":2021,"finding":"ALDH2 overexpression in APP/PS1 Alzheimer's mouse model attenuates cardiac dysfunction by suppressing ferroptosis via the SP1/ACSL4 pathway: ALDH2 reduces lipid peroxidation, decreases ACSL4 and SP1 expression, and prevents ferroptosis; Aβ-induced ferroptosis and cardiomyocyte injury in vitro is rescued by ALDH2 transgene or Alda-1 activator.","method":"ALDH2 transgenic crossed with APP/PS1 mice; in vitro Aβ treatment of cardiomyocytes; Alda-1 treatment; SP1 inhibitor (tolfenamic acid) and ACSL4 inhibitor (triacsin C) pharmacological validation","journal":"Acta pharmacologica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse model plus in vitro mechanistic validation with pharmacological tools, single lab","pmids":["33767380"],"is_preprint":false},{"year":2022,"finding":"Wild-type ALDH2 directly interacts with Rac2 in macrophages and attenuates its K48-linked polyubiquitination at lysine 123, preventing Rac2 degradation; the rs671 mutant ALDH2 destabilizes Rac2, impairing macrophage efferocytosis and accelerating atherosclerosis. Bone marrow transplant experiments confirmed the macrophage-specific role.","method":"Bone marrow transplantation (APOE-/-ALDH2-/- to APOE-/-); RNA-seq, proteomics, co-immunoprecipitation; Rac2 ubiquitination assays; human macrophage studies from rs671 carriers","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP with ubiquitination site mapping, bone marrow transplant in vivo, validated in human macrophages from mutation carriers, multiple orthogonal methods","pmids":["35354308"],"is_preprint":false},{"year":2022,"finding":"EHMT2 epigenetically represses ALDH2 expression (via H3K9 methylation); NFYA cooperatively regulates ALDH2 transcription; ALDH2 overexpression activates the RAS/RAF oncogenic pathway to confer paclitaxel resistance in non-small cell lung cancer; ALDH2 inhibition or EHMT2 inhibitor restores paclitaxel sensitivity.","method":"Gene microarray, cell line and xenograft functional studies, pharmacological ALDH2 inhibition, EHMT2 inhibition with JIB04, clinicopathological patient analysis","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell lines and in vivo xenografts, epigenetic mechanism defined, pathway validated, single lab","pmids":["35477569"],"is_preprint":false},{"year":2022,"finding":"ALDH2 deficiency increases autophagy in pulmonary artery smooth muscle cells via the ERK1/2-Beclin-1 pathway, contributing to PASMC migration/proliferation and pulmonary hypertension; ALDH2 knockout in mice exacerbates hypoxia/SU5416-induced PH with increased 4-HNE and autophagosomes.","method":"ALDH2 KO mice; lentiviral ALDH2 knockdown in human PASMCs; PDGF-BB stimulation; ERK1/2-Beclin-1 autophagy pathway analysis; electron microscopy; hemodynamic monitoring","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse and cell knockdown with mechanistic pathway analysis, single lab","pmids":["35770049"],"is_preprint":false},{"year":2022,"finding":"In zebrafish melanocyte stem cells, Aldh2 activity is required not only for aldehyde clearance but specifically to generate formate (a one-carbon building block for nucleotide biosynthesis) through formaldehyde metabolism, enabling McSC progeny generation during regeneration; disrupting the 1C cycle with methotrexate causes melanocyte regeneration defects; purines are sufficient to rescue Aldh2-deficient McSC regeneration.","method":"Live imaging coupled with scRNA-sequencing; aldh2 loss-of-function in zebrafish; metabolic rescue experiments with formate and purines; methotrexate treatment","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with metabolic rescue in vivo, novel mechanistic finding, single lab","pmids":["35485397"],"is_preprint":false},{"year":2023,"finding":"p53 directly binds to ALDH2 and prevents formation of its active tetramer; p53 also indirectly limits pyruvate production (a natural ALDH2 activator), thereby repressing ALDH2 enzymatic activity, reducing acetyl-CoA and histone acetylation, and suppressing SCD1 expression to protect against alcohol-induced fatty liver.","method":"Biochemical binding assay (p53-ALDH2 direct interaction); p53-deficient mice with ALDH2 depletion rescue; SCD1 overexpression/knockdown studies; acetyl-CoA and histone acetylation measurements","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct protein-protein interaction demonstrated, genetic rescue experiments in mice, multiple orthogonal biochemical readouts, single lab","pmids":["36825429"],"is_preprint":false},{"year":2023,"finding":"ALDH2 directly binds LIN28B (an ELK3 mRNA stability regulator) in endothelial cells, hindering LIN28B binding to ELK3 mRNA and thereby suppressing ELK3 expression; ALDH2-specific knockout in endothelial cells increases ELK3 expression, enhances endothelial barrier integrity via focal adhesion/tight junction upregulation, and suppresses early aortic dilation in AAA.","method":"Endothelial cell-specific ALDH2 knockdown/knockout; single-cell RNA sequencing; mRNA sequencing; direct binding study (ALDH2-LIN28B); AAV-mediated ELK3 modulation; Ang II-induced AAA mouse model","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ALDH2-LIN28B interaction demonstrated, cell-type-specific KO with in vivo validation, single lab","pmids":["37822152"],"is_preprint":false},{"year":2023,"finding":"ALDH2 alleviates LPS-induced cardiac dysfunction, inflammation, and apoptosis through inhibition of the cGAS/STING signaling pathway; Alda-1 activation of ALDH2 suppresses cGAS/STING while daidzin inhibition exacerbates injury; cGAS siRNA knockdown abolishes the synergistic effect of daidzin, placing ALDH2 upstream of cGAS/STING.","method":"LPS-induced mouse and H9C2 cell cardiac injury models; Alda-1 and daidzin pharmacological modulation; cGAS siRNA knockdown; cardiac function by echocardiography; ELISA and flow cytometry","journal":"Molecular medicine (Cambridge, Mass.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic epistasis placing ALDH2 upstream of cGAS/STING, multiple readouts, single lab","pmids":["38124089"],"is_preprint":false},{"year":2023,"finding":"ALDH2 inhibits myocardial pyroptosis in sepsis by preventing HDAC3 translocation from nucleus to mitochondria, thereby protecting HADHA acetylation; acetylated HADHA supports mitochondrial fatty acid β-oxidation; ALDH2 deficiency allows HDAC3 translocation → HADHA deacetylation → toxic lipid accumulation → mROS and ox-mtDNA release → NLRP3 inflammasome activation and GSDMD-dependent pyroptosis.","method":"LPS septic shock mouse model; ALDH2 knockout/knockdown; HDAC3 subcellular fractionation; HADHA acetylation assays; HDAC3 and HADHA siRNA epistasis experiments","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — detailed epistasis with KO and siRNA knockdowns, subcellular fractionation, single lab","pmids":["36992838"],"is_preprint":false},{"year":2023,"finding":"CHKB-DT lncRNA physically interacts with ALDH2 mRNA and FUS protein through a GGUG motif, protecting ALDH2 mRNA from degradation; CHKB-DT knockdown aggravates ALDH2 mRNA degradation and 4-HNE production; restoring ALDH2 in CHKB-DT+/- mice rescues cardiac dilation and dysfunction in dilated cardiomyopathy.","method":"RNA antisense purification; RNA pull-down; luciferase assay; CRISPR KO mouse model; quantitative proteomics and ribosome profiling; ALDH2 rescue in CHKB-DT+/- mice","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct RNA-protein interaction demonstrated by multiple methods, in vivo genetic rescue, multiple orthogonal approaches in single study","pmids":["38299365"],"is_preprint":false},{"year":2023,"finding":"SGLT2 inhibitor empagliflozin ameliorates ALDH2*2-induced endothelial cell dysfunction by inhibiting Na+/H+-exchanger 1 (NHE-1) and activating AKT and eNOS pathways, reducing oxidative stress and restoring NO production; CRISPR-Cas9-corrected ALDH2*2 iPSC-ECs confirm the causal role of ALDH2*2 in EC dysfunction.","method":"iPSC-derived ECs from ALDH2*2 carriers; CRISPR-Cas9 correction; empagliflozin treatment; ALDH2*2 knock-in mice; human vasodilation clinical assessment; AKT/eNOS pathway analysis","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — isogenic CRISPR correction, multiple model systems (iPSC, mice, human subjects), defined molecular pathway, single rigorous study","pmids":["36696485"],"is_preprint":false},{"year":2023,"finding":"ALDH2 activator AD-9308 treatment in Aldh2 wild-type and Glu504Lys knock-in mice reduces 4-HNE-adducted proteins in brown adipose tissue mitochondria; ALDH2 deficiency in BAT leads to 4-HNE adduction of proteins involved in fatty acid oxidation and electron transport chain, decreasing fatty acid oxidation and mitochondrial respiration, impairing adaptive thermogenesis and promoting diet-induced obesity, glucose intolerance, and fatty liver.","method":"Aldh2 Glu504Lys knock-in mice; high-fat diet challenge; BAT proteomics (4-HNE-adducted proteins); mitochondrial respiration assays; AD-9308 pharmacological treatment","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — proteomic identification of ALDH2 substrates/targets, physiological knockin model, in vitro mitochondrial assays, pharmacological rescue, single rigorous study","pmids":["37749090"],"is_preprint":false},{"year":2024,"finding":"ALDH2 deficiency increases cGAS stability in macrophages by reducing interaction between USP14 (a deubiquitinase) and cGAS; specifically, ALDH2 enzymatic activity reduces 4-HNE accumulation, which decreases USP14-cGAS interaction, allowing K48-linked polyubiquitination degradation of cGAS at lysine 282; ALDH2 deficiency therefore activates cGAS-STING pathway, promoting proinflammatory macrophage polarization and atherosclerosis.","method":"ALDH2-KO/ApoE-KO bone marrow transplantation; mechanistic Co-IP and ubiquitination assays; pharmacological cGAS inhibition (RU.521); USP14 knockdown; human macrophages from rs671 carriers","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — bone marrow transplant in vivo, direct K48-ubiquitination site mapping, multiple genetic and pharmacological epistasis experiments, validated in human cells","pmids":["39178733"],"is_preprint":false},{"year":2024,"finding":"ALDH2 deficiency exacerbates myocardial ischemia/reperfusion injury by promoting neutrophil extracellular trap (NETosis) formation via the endoplasmic reticulum stress/microsomal glutathione S-transferase 2/leukotriene C4 (LTC4)/NOX2 pathway; PAD4 knockout or NETosis-inhibiting drugs (GSK484, DNase1) substantially attenuate myocardial damage in ALDH2 KO mice.","method":"ALDH2 KO, PAD4 KO, and ALDH2/PAD4 double KO mice; myocardial I/R model; human STEMI patient cohort (n=308); NETosis pathway mechanistic studies; pranlukast (LTC4 receptor antagonist) treatment","journal":"European heart journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — double KO genetic epistasis, mechanistic pathway defined, validated in human clinical cohort, multiple pharmacological interventions","pmids":["38666340"],"is_preprint":false},{"year":2024,"finding":"ALDH2 promotes K48-linked polyubiquitination and degradation of PAD4 by facilitating PAD4 binding to the E3 ubiquitin ligase CHIP, thereby inhibiting NETosis in neutrophils; ALDH2 deficiency reduces PAD4 ubiquitination, increases NETosis, promotes vascular leakage, and exacerbates septic ARDS.","method":"Aldh2-KO and Aldh2rs671 knock-in mice; sepsis models; PAD4 ubiquitination assays; CHIP E3 ligase Co-IP; Alda-1 pharmacological rescue; human ARDS patient samples","journal":"Cellular & molecular immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct biochemical ubiquitination mechanism with CHIP Co-IP, multiple genetic models (KO + knockin), human patient validation","pmids":["38472357"],"is_preprint":false},{"year":2023,"finding":"HSPA8 (Heat Shock 70-kDa Protein 8) translocates to mitochondria under oxygen-glucose deprivation and binds ALDH2, inhibiting its enzymatic activity and promoting fibroblast senescence; siRNA knockdown of HSPA8 increases ALDH2 activity and reduces OGD-induced senescence markers.","method":"Co-immunoprecipitation and mass spectrometry identification of ALDH2-HSPA8 interaction; HSPA8 siRNA knockdown; OGD fibroblast model; ALDH2 enzyme activity assays; mitochondrial fractionation","journal":"Antioxidants (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP/MS interaction identified, siRNA genetic validation, functional ALDH2 activity readout, single lab","pmids":["38247467"],"is_preprint":false},{"year":2021,"finding":"PKCε activation promotes translocation to mitochondria and phosphorylation of ALDH2; activation of the mitochondrial PKCε-ALDH2 axis is required for recovery from 4-HNE-induced mechanical pain hypersensitivity; ALDH2-deficient knockin mice display increased 4-HNE nociceptive behavior and fail to respond to PKCε activator treatment.","method":"PKCε knockout mice; ALDH2-deficient knockin mice; PKCε activator peptide (ΨεHSP90); 4-HNE and carrageenan pain models; mechanical hypersensitivity measurements","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — double genetic KO/KI epistasis with pharmacological rescue, functional pain readout, single lab","pmids":["34944441"],"is_preprint":false},{"year":2016,"finding":"ALDH2 forms homodimers through hydrogen bonding between Glu487 and Arg475 residues; two ALDH2 homodimers form an active tetramer. ALDH2 has dehydrogenase, esterase, and reductase activities with main substrates being aldehydes, 4-nitrophenyl acetate, and nitroglycerin, respectively. Computational modeling predicts that inactive ALDH2*2 mutant subunits can heterotetramerize with ALDH1B1, potentially explaining lack of compensatory ALDH1B1 activity in ALDH2*2 individuals.","method":"Structural analysis of ALDH2 homodimerization domains; enzymatic activity characterization; computational molecular modeling of ALDH2-ALDH1B1 heterotetramerization","journal":"Nihon eiseigaku zasshi. Japanese journal of hygiene","confidence":"Medium","confidence_rationale":"Tier 1–3 / Weak — structural/biochemical characterization is established, heterotetramerization is computational prediction only; mixed evidence quality","pmids":["26832618","23247008"],"is_preprint":false},{"year":2020,"finding":"Novel non-East Asian ALDH2 missense variants identified in Latino, African, South Asian, and Finnish populations show significantly reduced enzymatic activity in vitro and increased ethanol-induced toxicity in 3T3 cells; a new activator Alda-64 corrects loss of activity in most of these new variants where Alda-1 was ineffective.","method":"In vitro enzymatic activity assays; 3T3 cell overexpression of variants; Alda-1 and Alda-64 pharmacological activation screening","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with enzymatic assays and cell-based validation, multiple variants tested, single lab","pmids":["32403082"],"is_preprint":false}],"current_model":"ALDH2 is a mitochondrial tetrameric aldehyde dehydrogenase (with dehydrogenase, esterase, and reductase activities) that detoxifies acetaldehyde and reactive lipid aldehydes (notably 4-HNE and malondialdehyde); beyond its canonical metabolic role, it protects genomic integrity by preventing acetaldehyde-DNA adduct formation, regulates multiple signaling pathways (AMPK, cGAS-STING, ERK1/2-Beclin1, PAD4/NETosis, PPARγ/CD36, LKB1-AMPK-SIRT1), is activated by PKCε-mediated phosphorylation, is transcriptionally regulated by the VHL-HNF4α axis and epigenetically by EHMT2/NFYA, is post-translationally inhibited by direct p53 binding that prevents tetramer formation, is protected from mRNA degradation by the lncRNA CHKB-DT, and interacts with Rac2 (stabilizing it against ubiquitin-proteasomal degradation), LIN28B (blocking ELK3 mRNA stabilization), and HSPA8 (which inhibits ALDH2 activity upon mitochondrial translocation); the common ALDH2*2 (Glu504Lys/E487K) dominant-negative variant reduces all these protective functions, increasing susceptibility to alcohol-related cancers, cardiovascular disease, neurodegeneration, and metabolic disorders."},"narrative":{"mechanistic_narrative":"ALDH2 is a mitochondrial tetrameric aldehyde dehydrogenase that detoxifies reactive aldehydes — both ethanol-derived acetaldehyde and the lipid-peroxidation product 4-hydroxynonenal (4-HNE) — and thereby protects genomic integrity, mitochondrial function, and multiple downstream signaling pathways [PMID:19874182, PMID:26577527, PMID:37749090]. The enzyme assembles into an active tetramer of homodimers stabilized by a Glu487-Arg475 hydrogen bond, and carries dehydrogenase, esterase, and reductase activities [PMID:26832618, PMID:23247008]. By clearing acetaldehyde, ALDH2 prevents the formation of acetaldehyde-derived DNA adducts; the loss-of-function ALDH2*2 (Glu487Lys/E504K) variant produces an unstable, dominant-negative subunit that allows adduct accumulation, DNA damage, and accelerated carcinogenesis, establishing ALDH2 as a genome-protective tumor suppressor in liver, esophagus, and lung [PMID:1733836, PMID:17040107, PMID:26150517, PMID:26374466, PMID:31071657]. By detoxifying 4-HNE, ALDH2 preserves mitochondrial respiration and constrains diverse stress pathways: it restrains cGAS-STING-driven inflammation, ERK1/2-Beclin1 autophagy, PPARγ/CD36 foam-cell formation, SP1/ACSL4 ferroptosis, and PAD4-dependent NETosis, while supporting AMPK and LKB1-AMPK-SIRT1 signaling [PMID:30853183, PMID:33767380, PMID:35770049, PMID:38124089, PMID:39178733, PMID:38666340, PMID:38472357, PMID:29463997, PMID:28027570]. ALDH2 also acts through direct protein interactions independent of bulk aldehyde clearance, stabilizing Rac2 against K48-ubiquitination in macrophages, binding LIN28B to suppress ELK3 in endothelium, and promoting CHIP-mediated PAD4 degradation [PMID:35354308, PMID:37822152, PMID:38472357]. Its activity is tuned by PKCε-mediated phosphorylation, transcriptionally by the VHL-HNF4α axis and EHMT2/NFYA, post-translationally by direct p53 binding that blocks tetramer formation, by mRNA stabilization through the CHKB-DT lncRNA, and by inhibitory mitochondrial HSPA8 binding [PMID:27575855, PMID:34944441, PMID:28643803, PMID:35477569, PMID:36825429, PMID:38299365, PMID:38247467]. Beyond aldehyde detoxification, Aldh2 also feeds one-carbon metabolism by generating formate for nucleotide biosynthesis during stem-cell regeneration [PMID:35485397]. Digenic ALDH2/ADH5 deficiency causes AMeD syndrome through failure of formaldehyde clearance [PMID:33355142].","teleology":[{"year":1992,"claim":"Established the molecular basis of the East Asian alcohol-flushing phenotype by showing the ALDH2*2 allele produces a catalytically inactive subunit, defining ALDH2 as the dominant acetaldehyde-clearing enzyme in humans.","evidence":"Allele-specific oligonucleotide genotyping with phenotypic correlation across populations","pmids":["1733836"],"confidence":"High","gaps":["Did not establish how a single substitution destabilizes the protein","No structural or mechanistic basis for the dominant-negative effect at this stage"]},{"year":2006,"claim":"Connected ALDH2 genotype to genotoxicity by demonstrating that deficient individuals accumulate acetaldehyde-derived DNA adducts in vivo, linking the enzyme's metabolic role to genome protection.","evidence":"LC/ESI-MS/MS quantification of DNA adducts in genotype-stratified human alcoholics","pmids":["17040107"],"confidence":"High","gaps":["Correlative in blood DNA, not causal in target tissues","Did not test cancer outcomes directly"]},{"year":2009,"claim":"Confirmed in vivo essentiality of ALDH2 for acetaldehyde detoxification using a clean genetic loss-of-function model.","evidence":"Aldh2 knockout mice with ethanol feeding and acetaldehyde inhalation; blood acetaldehyde measurement","pmids":["19874182"],"confidence":"High","gaps":["Acute toxicity readout did not address chronic disease or signaling roles"]},{"year":2015,"claim":"Established ALDH2 as a tumor suppressor that maintains genomic stability, and showed the E487K knockin is dominant-negative through increased protein turnover.","evidence":"Endogenous-locus knockin mice with carcinogen treatment, DNA damage assays, and human HCC tissue; KO/KD/OE in esophageal keratinocytes","pmids":["26150517","26374466"],"confidence":"High","gaps":["Mechanism by which adducts drive transformation not fully resolved","Tissue-specific susceptibility determinants not defined"]},{"year":2016,"claim":"Defined the structural and enzymatic basis of ALDH2 function — tetramer assembly via Glu487-Arg475 and three catalytic activities — and the regulatory PKCε phosphorylation that activates the enzyme.","evidence":"Structural/biochemical characterization and computational modeling; siRNA and pharmacological activation in 3T3-L1 preadipocytes","pmids":["26832618","23247008","27575855"],"confidence":"Medium","gaps":["ALDH1B1 heterotetramerization is computational prediction only","No high-resolution structure of the ALDH2*2 tetramer reported here"]},{"year":2017,"claim":"Identified upstream transcriptional control of ALDH2 through direct VHL-driven HNF4α activation at the ALDH2 promoter, linking expression to renal cancer drug response.","evidence":"Subtractive proteomics, promoter binding assay, RNAi/overexpression, and patient tissue correlation in ccRCC","pmids":["28643803"],"confidence":"High","gaps":["Generalizability of this axis beyond renal cells unknown"]},{"year":2016,"claim":"Linked ALDH2 to anti-metastatic signaling by showing its control of acetaldehyde/redox status activates AMPK to suppress HCC migration and invasion.","evidence":"Reciprocal gain/loss-of-function in HCC lines and xenografts with AMPK pathway analysis","pmids":["28027570"],"confidence":"Medium","gaps":["Direct mechanism connecting redox state to AMPK not fully defined","Single lab"]},{"year":2018,"claim":"Extended ALDH2's protective role to 4-HNE-driven cardiac pathology, defining the LKB1-AMPK-SIRT1 and mast-cell PKCε-ALDH2 axes in ischemia/reperfusion.","evidence":"Ex vivo I/R hearts, KO mice, AAV9 cardiac overexpression, SIRT1 carbonylation and LKB1-AMPK Co-IP","pmids":["29463997","29446730"],"confidence":"Medium","gaps":["Single lab models","Quantitative contribution of each pathway to outcome unclear"]},{"year":2019,"claim":"Demonstrated that 4-HNE accumulation under ALDH2 deficiency drives vascular and metabolic disease through PPARγ/CD36 foam-cell formation, HIF-1α/Drp1 mitochondrial fission, and DNA damage in lung cancer.","evidence":"KO macrophages, cell-type-specific AAV overexpression in PASMCs, transgenic/KO mice, and reciprocal manipulation in lung adenocarcinoma cells","pmids":["30853183","31510791","31071657"],"confidence":"High","gaps":["Cell-type-specific specificity of 4-HNE targets only partly mapped","Direct vs indirect effects on each pathway not always separated"]},{"year":2020,"claim":"Revealed non-catalytic and metabolic roles: ALDH2 interacts with the myocardin/miR-31-5p axis in VSMCs, generates formate for one-carbon metabolism in regeneration, and combined ALDH2/ADH5 deficiency causes AMeD syndrome; new disease variants beyond East Asian populations were also catalogued.","evidence":"Mouse AAD models and human VSMCs; zebrafish aldh2 loss-of-function with formate/purine rescue; patient genetics and Adh5/Aldh2 double-KO mice; in vitro variant enzymatic assays","pmids":["32428930","35485397","33355142","32403082"],"confidence":"High","gaps":["Mechanism of ALDH2-myocardin interaction is Medium-confidence","Relevance of formate generation to mammalian tissues not established here"]},{"year":2022,"claim":"Established direct protein-stabilization functions: ALDH2 binds Rac2 and protects it from K48-ubiquitination to support macrophage efferocytosis, while epigenetic EHMT2/NFYA control of ALDH2 modulates RAS/RAF-driven chemoresistance, and autophagy is restrained via ERK1/2-Beclin1.","evidence":"Bone marrow transplant, Co-IP with ubiquitination site mapping, human carrier macrophages, microarray, and KO mouse PH models","pmids":["35354308","35477569","35770049"],"confidence":"High","gaps":["Whether Rac2 stabilization is enzymatic-activity-dependent unclear","EHMT2/NFYA findings Medium-confidence"]},{"year":2023,"claim":"Mapped a multilayered regulatory network: p53 directly blocks ALDH2 tetramerization, CHKB-DT/FUS stabilizes ALDH2 mRNA, HSPA8 inhibits the enzyme in mitochondria, and LIN28B-ELK3 and cGAS-STING/HDAC3-HADHA axes mediate vascular, septic, and inflammatory protection; ALDH2*2 endothelial dysfunction was confirmed in isogenic CRISPR-corrected iPSC-ECs.","evidence":"Direct binding assays, genetic rescue mice, RNA pull-down, Co-IP/MS, subcellular fractionation, and CRISPR-corrected iPSC-EC and knockin models","pmids":["36825429","38299365","38247467","37822152","38124089","36992838","36696485","37749090"],"confidence":"High","gaps":["Hierarchy and crosstalk among these regulators not integrated","Several downstream signaling links are Medium-confidence single-lab studies"]},{"year":2024,"claim":"Defined ALDH2's control of innate immunity and NETosis: it tunes cGAS stability via 4-HNE/USP14, promotes CHIP-dependent PAD4 degradation, and limits ER-stress/LTC4/NOX2-driven NETosis to protect against atherosclerosis, sepsis-ARDS, and myocardial I/R injury.","evidence":"Bone marrow transplant, K48-ubiquitination site mapping, CHIP Co-IP, double-KO (ALDH2/PAD4) epistasis, knockin mice, and human STEMI/ARDS cohorts","pmids":["39178733","38472357","38666340"],"confidence":"High","gaps":["Whether PAD4/cGAS regulation requires catalytic activity vs scaffolding not fully separated","Integration with the broader regulatory network unresolved"]},{"year":null,"claim":"How ALDH2's diverse non-catalytic protein-stabilization and signaling functions (Rac2, PAD4, cGAS, LIN28B) are mechanistically partitioned from its enzymatic aldehyde-clearance role, and how its many regulators are coordinated in vivo, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model distinguishing enzymatic vs scaffolding contributions","No high-resolution structural basis for partner interactions","Tissue-specific dominance of competing pathways undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[2,5,27,33]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[33]},{"term_id":"GO:0016209","term_label":"antioxidant activity","supporting_discovery_ids":[5,27]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[17,30]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[5,27,31,32]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,27]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,3,4,15]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[23,28,29,30]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,12,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[16,24]}],"complexes":[],"partners":["RAC2","LIN28B","HSPA8","PAD4","P53","CGAS","PRKCE","FUS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P05091","full_name":"Aldehyde dehydrogenase, mitochondrial","aliases":["ALDH class 2","ALDH-E2","ALDHI"],"length_aa":517,"mass_kda":56.4,"function":"Required for clearance of cellular formaldehyde, a cytotoxic and carcinogenic metabolite that induces DNA damage","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/P05091/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ALDH2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ALDH2","total_profiled":1310},"omim":[{"mim_id":"619151","title":"AMED SYNDROME, DIGENIC; AMEDS","url":"https://www.omim.org/entry/619151"},{"mim_id":"614675","title":"BONE MARROW FAILURE SYNDROME 1; BMFS1","url":"https://www.omim.org/entry/614675"},{"mim_id":"613984","title":"FANCD2 GENE; FANCD2","url":"https://www.omim.org/entry/613984"},{"mim_id":"610251","title":"ALCOHOL SENSITIVITY, ACUTE","url":"https://www.omim.org/entry/610251"},{"mim_id":"600728","title":"NUCLEAR FACTOR I/B; NFIB","url":"https://www.omim.org/entry/600728"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":801.4}],"url":"https://www.proteinatlas.org/search/ALDH2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P05091","domains":[{"cath_id":"3.40.605.10","chopping":"38-286_490-503","consensus_level":"high","plddt":98.7892,"start":38,"end":503},{"cath_id":"3.40.309.10","chopping":"289-478","consensus_level":"high","plddt":98.697,"start":289,"end":478}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P05091","model_url":"https://alphafold.ebi.ac.uk/files/AF-P05091-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P05091-F1-predicted_aligned_error_v6.png","plddt_mean":95.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ALDH2","jax_strain_url":"https://www.jax.org/strain/search?query=ALDH2"},"sequence":{"accession":"P05091","fasta_url":"https://rest.uniprot.org/uniprotkb/P05091.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P05091/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P05091"}},"corpus_meta":[{"pmid":"1733836","id":"PMC_1733836","title":"Distribution of ADH2 and ALDH2 genotypes in different populations.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1733836","citation_count":442,"is_preprint":false},{"pmid":"17718397","id":"PMC_17718397","title":"ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review.","date":"2007","source":"Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism","url":"https://pubmed.ncbi.nlm.nih.gov/17718397","citation_count":275,"is_preprint":false},{"pmid":"16103445","id":"PMC_16103445","title":"Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach.","date":"2005","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16103445","citation_count":173,"is_preprint":false},{"pmid":"16822169","id":"PMC_16822169","title":"Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians.","date":"2006","source":"Psychological bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/16822169","citation_count":169,"is_preprint":false},{"pmid":"32428930","id":"PMC_32428930","title":"Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype.","date":"2020","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/32428930","citation_count":157,"is_preprint":false},{"pmid":"21664374","id":"PMC_21664374","title":"ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.","date":"2011","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21664374","citation_count":136,"is_preprint":false},{"pmid":"33767380","id":"PMC_33767380","title":"Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis.","date":"2021","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/33767380","citation_count":120,"is_preprint":false},{"pmid":"34221859","id":"PMC_34221859","title":"The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.","date":"2021","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/34221859","citation_count":119,"is_preprint":false},{"pmid":"22102315","id":"PMC_22102315","title":"Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians.","date":"2011","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22102315","citation_count":112,"is_preprint":false},{"pmid":"17040107","id":"PMC_17040107","title":"Increased DNA damage in ALDH2-deficient alcoholics.","date":"2006","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/17040107","citation_count":106,"is_preprint":false},{"pmid":"26150517","id":"PMC_26150517","title":"ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26150517","citation_count":77,"is_preprint":false},{"pmid":"33355142","id":"PMC_33355142","title":"Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33355142","citation_count":73,"is_preprint":false},{"pmid":"31510791","id":"PMC_31510791","title":"ALDH2 (Aldehyde Dehydrogenase 2) Protects Against Hypoxia-Induced Pulmonary Hypertension.","date":"2019","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31510791","citation_count":72,"is_preprint":false},{"pmid":"38666340","id":"PMC_38666340","title":"Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.","date":"2024","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/38666340","citation_count":71,"is_preprint":false},{"pmid":"28027570","id":"PMC_28027570","title":"Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.","date":"2017","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/28027570","citation_count":67,"is_preprint":false},{"pmid":"31689484","id":"PMC_31689484","title":"Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.","date":"2019","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31689484","citation_count":62,"is_preprint":false},{"pmid":"32403082","id":"PMC_32403082","title":"Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicity.","date":"2020","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/32403082","citation_count":60,"is_preprint":false},{"pmid":"31071657","id":"PMC_31071657","title":"ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage.","date":"2019","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31071657","citation_count":59,"is_preprint":false},{"pmid":"35477569","id":"PMC_35477569","title":"An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.","date":"2022","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35477569","citation_count":57,"is_preprint":false},{"pmid":"29155365","id":"PMC_29155365","title":"Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29155365","citation_count":57,"is_preprint":false},{"pmid":"38124089","id":"PMC_38124089","title":"ALDH2 mitigates LPS-induced cardiac dysfunction, inflammation, and apoptosis through the cGAS/STING pathway.","date":"2023","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38124089","citation_count":56,"is_preprint":false},{"pmid":"31368097","id":"PMC_31368097","title":"ALDH2 and Cardiovascular Disease.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368097","citation_count":55,"is_preprint":false},{"pmid":"36936815","id":"PMC_36936815","title":"ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: Comprehensive multi-omics analysis.","date":"2023","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/36936815","citation_count":55,"is_preprint":false},{"pmid":"28643803","id":"PMC_28643803","title":"VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28643803","citation_count":52,"is_preprint":false},{"pmid":"28382610","id":"PMC_28382610","title":"The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.","date":"2016","source":"Acta neurologica Taiwanica","url":"https://pubmed.ncbi.nlm.nih.gov/28382610","citation_count":52,"is_preprint":false},{"pmid":"26804999","id":"PMC_26804999","title":"ALDH2 gene polymorphism in different types of cancers and its clinical significance.","date":"2016","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26804999","citation_count":50,"is_preprint":false},{"pmid":"31871948","id":"PMC_31871948","title":"ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation.","date":"2019","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/31871948","citation_count":49,"is_preprint":false},{"pmid":"36696485","id":"PMC_36696485","title":"SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant.","date":"2023","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36696485","citation_count":48,"is_preprint":false},{"pmid":"16332725","id":"PMC_16332725","title":"A gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan.","date":"2005","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16332725","citation_count":47,"is_preprint":false},{"pmid":"7573775","id":"PMC_7573775","title":"CYP2E1 and ALDH2 genotypes and alcohol dependence in Japanese.","date":"1995","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/7573775","citation_count":44,"is_preprint":false},{"pmid":"37749090","id":"PMC_37749090","title":"A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37749090","citation_count":42,"is_preprint":false},{"pmid":"26374466","id":"PMC_26374466","title":"Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26374466","citation_count":41,"is_preprint":false},{"pmid":"35354308","id":"PMC_35354308","title":"Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.","date":"2022","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35354308","citation_count":38,"is_preprint":false},{"pmid":"35670037","id":"PMC_35670037","title":"Impacts of ADH1B rs1229984 and ALDH2 rs671 polymorphisms on risks of alcohol-related disorder and cancer.","date":"2022","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35670037","citation_count":35,"is_preprint":false},{"pmid":"14568296","id":"PMC_14568296","title":"Effects of ALDH2 gene polymorphisms and alcohol-drinking behavior on micronuclei frequency in non-smokers.","date":"2003","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/14568296","citation_count":35,"is_preprint":false},{"pmid":"21157980","id":"PMC_21157980","title":"Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China.","date":"2010","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21157980","citation_count":34,"is_preprint":false},{"pmid":"29463997","id":"PMC_29463997","title":"Targeting ALDH2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29463997","citation_count":33,"is_preprint":false},{"pmid":"38763322","id":"PMC_38763322","title":"ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation.","date":"2024","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/38763322","citation_count":30,"is_preprint":false},{"pmid":"33604259","id":"PMC_33604259","title":"Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis.","date":"2021","source":"Journal of clinical and translational hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33604259","citation_count":30,"is_preprint":false},{"pmid":"26577527","id":"PMC_26577527","title":"Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/26577527","citation_count":30,"is_preprint":false},{"pmid":"25680115","id":"PMC_25680115","title":"Association between Glu504Lys polymorphism of ALDH2 gene and cancer risk: a meta-analysis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25680115","citation_count":29,"is_preprint":false},{"pmid":"24633362","id":"PMC_24633362","title":"ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24633362","citation_count":29,"is_preprint":false},{"pmid":"19874182","id":"PMC_19874182","title":"Characteristics of aldehyde dehydrogenase 2 (Aldh2) knockout mice.","date":"2009","source":"Toxicology mechanisms and methods","url":"https://pubmed.ncbi.nlm.nih.gov/19874182","citation_count":27,"is_preprint":false},{"pmid":"27038040","id":"PMC_27038040","title":"ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.","date":"2016","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27038040","citation_count":27,"is_preprint":false},{"pmid":"26212265","id":"PMC_26212265","title":"ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications.","date":"2017","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/26212265","citation_count":26,"is_preprint":false},{"pmid":"27575855","id":"PMC_27575855","title":"PKC-ALDH2 Pathway Plays a Novel Role in Adipocyte Differentiation.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27575855","citation_count":26,"is_preprint":false},{"pmid":"31368105","id":"PMC_31368105","title":"ALDH2 and Stroke: A Systematic Review of the Evidence.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368105","citation_count":25,"is_preprint":false},{"pmid":"36992838","id":"PMC_36992838","title":"ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36992838","citation_count":25,"is_preprint":false},{"pmid":"39178733","id":"PMC_39178733","title":"ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39178733","citation_count":24,"is_preprint":false},{"pmid":"38299365","id":"PMC_38299365","title":"LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2.","date":"2024","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/38299365","citation_count":24,"is_preprint":false},{"pmid":"26782498","id":"PMC_26782498","title":"Aldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysis.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26782498","citation_count":24,"is_preprint":false},{"pmid":"30921184","id":"PMC_30921184","title":"Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.","date":"2019","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30921184","citation_count":24,"is_preprint":false},{"pmid":"35114580","id":"PMC_35114580","title":"Accumulation of acetaldehyde in aldh2.1-/- zebrafish causes increased retinal angiogenesis and impaired glucose metabolism.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35114580","citation_count":24,"is_preprint":false},{"pmid":"28249782","id":"PMC_28249782","title":"ALDH2 restores exhaustive exercise-induced mitochondrial dysfunction in skeletal muscle.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28249782","citation_count":24,"is_preprint":false},{"pmid":"27918674","id":"PMC_27918674","title":"miR-224 Affects Mammary Epithelial Cell Apoptosis and Triglyceride Production by Downregulating ACADM and ALDH2 Genes.","date":"2016","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27918674","citation_count":24,"is_preprint":false},{"pmid":"37209766","id":"PMC_37209766","title":"ALDH2 ameliorates ethanol-induced gastric ulcer through suppressing NLPR3 inflammasome activation and ferroptosis.","date":"2023","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/37209766","citation_count":23,"is_preprint":false},{"pmid":"30853183","id":"PMC_30853183","title":"ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30853183","citation_count":23,"is_preprint":false},{"pmid":"27714678","id":"PMC_27714678","title":"Roles of defective ALDH2 polymorphism on liver protection and cancer development.","date":"2016","source":"Environmental health and preventive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27714678","citation_count":23,"is_preprint":false},{"pmid":"36825429","id":"PMC_36825429","title":"p53 protects against alcoholic fatty liver disease via ALDH2 inhibition.","date":"2023","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/36825429","citation_count":22,"is_preprint":false},{"pmid":"37822152","id":"PMC_37822152","title":"Early Progression of Abdominal Aortic Aneurysm is Decelerated by Improved Endothelial Barrier Function via ALDH2-LIN28B-ELK3 Signaling.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37822152","citation_count":22,"is_preprint":false},{"pmid":"35715591","id":"PMC_35715591","title":"ALDH2 Hampers Immune Escape in Liver Hepatocellular Carcinoma through ROS/Nrf2-mediated Autophagy.","date":"2022","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35715591","citation_count":22,"is_preprint":false},{"pmid":"33188956","id":"PMC_33188956","title":"ALDH2 mutation promotes skeletal muscle atrophy in mice via accumulation of oxidative stress.","date":"2020","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/33188956","citation_count":21,"is_preprint":false},{"pmid":"27808372","id":"PMC_27808372","title":"Role of ADH1B rs1229984 and ALDH2 rs671 gene polymorphisms in the development of Alzheimer's disease.","date":"2016","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/27808372","citation_count":21,"is_preprint":false},{"pmid":"38472357","id":"PMC_38472357","title":"Neutrophil ALDH2 is a new therapeutic target for the effective treatment of sepsis-induced ARDS.","date":"2024","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38472357","citation_count":20,"is_preprint":false},{"pmid":"31368098","id":"PMC_31368098","title":"The Bidirectional Effect of Defective ALDH2 Polymorphism and Disease Prevention.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368098","citation_count":20,"is_preprint":false},{"pmid":"18336671","id":"PMC_18336671","title":"SPINK1, ADH2, and ALDH2 gene variants and alcoholic chronic pancreatitis in Japan.","date":"2008","source":"Journal of gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/18336671","citation_count":20,"is_preprint":false},{"pmid":"37693648","id":"PMC_37693648","title":"Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer's disease.","date":"2023","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37693648","citation_count":19,"is_preprint":false},{"pmid":"33421985","id":"PMC_33421985","title":"Association between ALDH2 and ADH1B Polymorphisms and the Risk for Colorectal Cancer in Koreans.","date":"2020","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/33421985","citation_count":19,"is_preprint":false},{"pmid":"26832618","id":"PMC_26832618","title":"[Fundamental Properties of Aldehyde Dehydrogenase 2 (ALDH2) and the Importance of the ALDH2 Polymorphism].","date":"2016","source":"Nihon eiseigaku zasshi. Japanese journal of hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/26832618","citation_count":19,"is_preprint":false},{"pmid":"25403981","id":"PMC_25403981","title":"Meta-analysis of association between ALDH2 rs671 polymorphism and essential hypertension in Asian populations.","date":"2014","source":"Herz","url":"https://pubmed.ncbi.nlm.nih.gov/25403981","citation_count":19,"is_preprint":false},{"pmid":"29383448","id":"PMC_29383448","title":"A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.","date":"2018","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/29383448","citation_count":19,"is_preprint":false},{"pmid":"31368107","id":"PMC_31368107","title":"ALDH2 and Cancer Therapy.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368107","citation_count":18,"is_preprint":false},{"pmid":"22292652","id":"PMC_22292652","title":"Esophageal squamous cell carcinoma and ALDH2 and ADH1B polymorphisms in Chinese females.","date":"2011","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/22292652","citation_count":18,"is_preprint":false},{"pmid":"29446730","id":"PMC_29446730","title":"Salvaging the Ischemic Heart: Gi-Coupled Receptors in Mast Cells Activate a PKCε/ALDH2 Pathway Providing Anti-RAS Cardioprotection.","date":"2018","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29446730","citation_count":18,"is_preprint":false},{"pmid":"25354396","id":"PMC_25354396","title":"Contribution of ALDH2 polymorphism to alcoholism-associated hypertension.","date":"2014","source":"Recent patents on endocrine, metabolic & immune drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/25354396","citation_count":17,"is_preprint":false},{"pmid":"38104741","id":"PMC_38104741","title":"ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolism.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38104741","citation_count":17,"is_preprint":false},{"pmid":"27189280","id":"PMC_27189280","title":"Aldehyde Dehydrogenase 2 (ALDH2) Polymorphism and the Risk of Alcoholic Liver Cirrhosis among East Asians: A Meta-Analysis.","date":"2016","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27189280","citation_count":17,"is_preprint":false},{"pmid":"35770049","id":"PMC_35770049","title":"Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35770049","citation_count":17,"is_preprint":false},{"pmid":"37657657","id":"PMC_37657657","title":"Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axis.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/37657657","citation_count":16,"is_preprint":false},{"pmid":"37183314","id":"PMC_37183314","title":"ALDH2 promotes cancer stemness and metastasis in colorectal cancer through activating β-catenin signaling.","date":"2023","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37183314","citation_count":16,"is_preprint":false},{"pmid":"39328412","id":"PMC_39328412","title":"Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39328412","citation_count":16,"is_preprint":false},{"pmid":"36939783","id":"PMC_36939783","title":"Origin and Spread of the ALDH2 Glu504Lys Allele.","date":"2021","source":"Phenomics (Cham, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36939783","citation_count":15,"is_preprint":false},{"pmid":"23247008","id":"PMC_23247008","title":"Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2.","date":"2012","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/23247008","citation_count":15,"is_preprint":false},{"pmid":"35346052","id":"PMC_35346052","title":"Association of ALDH2 rs671 and MTHFR rs1801133 polymorphisms with hypertension among Hakka people in Southern China.","date":"2022","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/35346052","citation_count":15,"is_preprint":false},{"pmid":"31368104","id":"PMC_31368104","title":"The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368104","citation_count":14,"is_preprint":false},{"pmid":"35404279","id":"PMC_35404279","title":"Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease.","date":"2022","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/35404279","citation_count":14,"is_preprint":false},{"pmid":"31368109","id":"PMC_31368109","title":"Aldehyde Dehydrogenase 2 (ALDH2) and Aging: Is There a Sensible Link?","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368109","citation_count":13,"is_preprint":false},{"pmid":"38247467","id":"PMC_38247467","title":"The Binding of HSPA8 and Mitochondrial ALDH2 Mediates Oxygen-Glucose Deprivation-Induced Fibroblast Senescence.","date":"2023","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38247467","citation_count":13,"is_preprint":false},{"pmid":"32446379","id":"PMC_32446379","title":"Astaxanthin improves osteopenia caused by aldehyde-stress resulting from Aldh2 mutation due to impaired osteoblastogenesis.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32446379","citation_count":13,"is_preprint":false},{"pmid":"39370484","id":"PMC_39370484","title":"ALDH2 alleviates inflammation and facilitates osteogenic differentiation of periodontal ligament stem cells in periodontitis by blocking ferroptosis via activating Nrf2.","date":"2024","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39370484","citation_count":13,"is_preprint":false},{"pmid":"39216560","id":"PMC_39216560","title":"Targeting ALDH2 to augment platinum-based chemosensitivity through ferroptosis in lung adenocarcinoma.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39216560","citation_count":12,"is_preprint":false},{"pmid":"39365551","id":"PMC_39365551","title":"Advances in Factors Affecting ALDH2 Activity and its Mechanisms.","date":"2024","source":"Cardiovascular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/39365551","citation_count":12,"is_preprint":false},{"pmid":"32223781","id":"PMC_32223781","title":"Folate, alcohol, ADH1B and ALDH2 and colorectal cancer risk.","date":"2020","source":"Public health nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/32223781","citation_count":12,"is_preprint":false},{"pmid":"31368108","id":"PMC_31368108","title":"ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31368108","citation_count":12,"is_preprint":false},{"pmid":"34944441","id":"PMC_34944441","title":"Activation of PKCε-ALDH2 Axis Prevents 4-HNE-Induced Pain in Mice.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/34944441","citation_count":12,"is_preprint":false},{"pmid":"28471244","id":"PMC_28471244","title":"ALDH2*2 and peer drinking in East Asian college students.","date":"2017","source":"The American journal of drug and alcohol abuse","url":"https://pubmed.ncbi.nlm.nih.gov/28471244","citation_count":12,"is_preprint":false},{"pmid":"38891060","id":"PMC_38891060","title":"Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) Protects against Binge Alcohol-Mediated Gut and Brain Injury.","date":"2024","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/38891060","citation_count":12,"is_preprint":false},{"pmid":"37406742","id":"PMC_37406742","title":"SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37406742","citation_count":12,"is_preprint":false},{"pmid":"35485397","id":"PMC_35485397","title":"Aldh2 is a lineage-specific metabolic gatekeeper in melanocyte stem cells.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35485397","citation_count":12,"is_preprint":false},{"pmid":"33060820","id":"PMC_33060820","title":"Alcohol consumption is associated with glaucoma severity regardless of ALDH2 polymorphism.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33060820","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54367,"output_tokens":9642,"usd":0.153865,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20140,"output_tokens":5050,"usd":0.113475,"stage2_stop_reason":"end_turn"},"total_usd":0.26734,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"The ALDH2*2 allele (Glu487Lys substitution) produces an inactive protein subunit that is unable to metabolize acetaldehyde, leading to acetaldehyde accumulation after alcohol consumption and associated flushing response.\",\n      \"method\": \"Allele-specific oligonucleotide hybridization of amplified genomic DNA; population genotyping with phenotypic correlation\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across 21 populations, direct genotype-phenotype correlation established\",\n      \"pmids\": [\"1733836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ALDH2-deficient alcoholics (ALDH2 1/2 genotype) accumulate significantly higher levels of acetaldehyde-derived DNA adducts (N2-ethyl-2'-deoxyguanosine, alpha-S- and alpha-R-methyl-gamma-hydroxy-1,N2-propano-2'-deoxyguanosine) in blood DNA compared to ALDH2 1/1 alcoholics, demonstrating that ALDH2 genotype directly affects acetaldehyde-induced genotoxic damage.\",\n      \"method\": \"LC/ESI-MS/MS quantification of acetaldehyde-derived DNA adducts in blood DNA from 44 Japanese alcoholic patients stratified by ALDH2 genotype\",\n      \"journal\": \"Chemical research in toxicology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biochemical measurement of DNA adducts in human subjects with defined genotype, single lab with rigorous quantitative MS method\",\n      \"pmids\": [\"17040107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Aldh2 knockout mice are more susceptible to ethanol and acetaldehyde-induced toxicity than wild-type mice, showing increased mortality when fed ethanol and more severe toxic symptoms (weight loss, higher blood acetaldehyde levels) upon acetaldehyde inhalation, confirming ALDH2's essential role in acetaldehyde detoxification in vivo.\",\n      \"method\": \"Knockout mouse model with ethanol feeding and acetaldehyde inhalation exposure; blood acetaldehyde measurement\",\n      \"journal\": \"Toxicology mechanisms and methods\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined phenotypic readout, multiple exposure paradigms, replicated across multiple published studies reviewed\",\n      \"pmids\": [\"19874182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The ALDH2(E487K) knockin mutation causes increased protein turnover and dominant-negative reduction of ALDH2 expression, impaired acetaldehyde clearance, increased sensitivity to alcohol-induced toxicity, increased DNA damage response in hepatocytes, and accelerated hepatocellular carcinoma development after carcinogen treatment, establishing ALDH2 as a tumor suppressor that maintains genomic stability.\",\n      \"method\": \"Knockin mice with E487K mutation at endogenous Aldh2 locus; carcinogen treatment; DNA damage assays; comparison with human HCC patient tissue\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — physiological knockin model, multiple orthogonal readouts, validated in human patient tissue\",\n      \"pmids\": [\"26150517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ALDH2 in esophageal keratinocytes protects against acetaldehyde-derived DNA damage (N2-ethylidene-2'-deoxyguanosine adducts): Aldh2-knockout mice show higher DNA adduct levels in esophagus after ethanol consumption; forced ALDH2 overexpression in human keratinocytes sharply reduces adduct levels; acetaldehyde induces ALDH2 expression in both mouse and human esophageal keratinocytes.\",\n      \"method\": \"Aldh2 knockout mice with ethanol exposure; ALDH2 knockdown and overexpression in human esophageal keratinocytes; DNA adduct quantification\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal genetic approaches (KO, KD, OE) with direct DNA damage readout in both mouse and human cell systems\",\n      \"pmids\": [\"26374466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"4-Hydroxynonenal (4-HNE) impairs ALDH2 activity and reduces mitochondrial respiration in H9C2 cardiomyocytes; ALDH2 inhibition (by DSF or siRNA knockdown) also reduces mitochondrial respiratory reserve capacity and increases cell death, establishing that ALDH2 activity is required for normal mitochondrial function in cardiomyocytes.\",\n      \"method\": \"4-HNE treatment, disulfiram inhibition, and siRNA knockdown of ALDH2 in H9C2 cells; Seahorse mitochondrial respiration assay; cell viability assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple inhibition methods (chemical + genetic) with functional metabolic readout, single lab\",\n      \"pmids\": [\"26577527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PKCε phosphorylates and activates ALDH2; PKCε-ALDH2 axis regulates adipogenesis through control of 4-HNE levels and PPARγ signaling. ALDH2 knockdown increases intracellular 4-HNE and attenuates adipocyte differentiation, while ALDH2 activation (Alda-1) or PKCε agonist treatment enhances adipogenesis.\",\n      \"method\": \"siRNA knockdown of ALDH2 and PKCε in 3T3-L1 preadipocytes; Alda-1 treatment; whole-genome microarray profiling; adipogenesis assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown plus pharmacological activation with gene expression profiling, single lab, multiple methods\",\n      \"pmids\": [\"27575855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ALDH2 inhibits hepatocellular carcinoma cell migration and invasion by altering redox status through regulation of acetaldehyde levels, which in turn activates the AMP-activated protein kinase (AMPK) signaling pathway; the ALDH2-acetaldehyde-redox-AMPK axis mediates the anti-metastatic function of ALDH2 in HCC.\",\n      \"method\": \"ALDH2 overexpression and knockdown in HCC cell lines and mouse xenografts; AMPK signaling analysis; migration/invasion assays\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain/loss-of-function, in vivo xenograft, pathway validation, single lab\",\n      \"pmids\": [\"28027570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"VHL transcriptionally regulates ALDH2 expression by binding the ALDH2 promoter region (-130 bp to -160 bp) and activating HNF-4α transcription; VHL deficiency reduces ALDH2 expression, and decreased ALDH2 contributes to enhanced anthracycline cytotoxicity in clear cell renal cell carcinoma.\",\n      \"method\": \"Subtractive proteomics, RNAi/overexpression verification, promoter binding assay, patient tissue correlation in ccRCC\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter binding demonstrated, validated by multiple approaches and human tissue correlation\",\n      \"pmids\": [\"28643803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Activation of Gi-coupled receptors (histamine H4, adenosine A3, sphingosine-1-phosphate S1P1) in cardiac mast cells sequentially activates PKCε and then ALDH2; increased ALDH2 enzymatic activity inhibits aldehyde-induced mast cell renin release, prevents local cardiac RAS activation, reduces norepinephrine release, and alleviates reperfusion arrhythmias.\",\n      \"method\": \"Ex vivo ischemia/reperfusion models in guinea pig and mouse hearts; human and murine mast cell lines; pharmacological receptor activation\",\n      \"journal\": \"Current medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ex vivo functional models with receptor pharmacology, mechanistic pathway defined, single lab\",\n      \"pmids\": [\"29446730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Chronic pain-induced 4-HNE accumulation causes SIRT1 carbonylative inactivation and impairs LKB1-AMPK interaction, increasing myocardial ischemia/reperfusion susceptibility; cardiac-specific ALDH2 upregulation (via AAV9-cTNT delivery) detoxifies 4-HNE, prevents SIRT1 carbonylation, restores LKB1-AMPK interaction, and reduces MI/R injury.\",\n      \"method\": \"CCD chronic pain model; ALDH2 KO mice; AAV9-mediated cardiac-specific ALDH2 overexpression; SIRT1 carbonylation assay; LKB1-AMPK co-immunoprecipitation\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and viral delivery approaches, molecular pathway validation including Co-IP, single lab\",\n      \"pmids\": [\"29463997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ALDH2 deficiency increases 4-HNE accumulation, which activates the 4-HNE/PPARγ/CD36 pathway: ALDH2-deficient macrophages show downregulated PPARγ and CD36 expression, suppressing foam cell formation induced by oxidized LDL (but not acetylated LDL).\",\n      \"method\": \"ALDH2-deficient and control mouse peritoneal macrophages; ox-LDL and ac-LDL treatment; CD36 inhibitor; Western blot; foam cell assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO macrophages with pharmacological confirmation, pathway validated, single lab\",\n      \"pmids\": [\"30853183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"4-Hydroxynonenal (4-HNE), a lipid peroxidation product not detoxified in ALDH2-deficient conditions, drives pulmonary hypertension by stabilizing HIF-1α and increasing Drp1 (Ser616) phosphorylation, promoting mitochondrial fission and PASMC proliferation; ALDH2 overexpression specifically in pulmonary artery smooth muscle cells (but not endothelial cells) prevents HPH development.\",\n      \"method\": \"ALDH2 transgenic and KO mice; chronic hypoxia model; AAV-mediated cell-type-specific ALDH2 overexpression (ICAM2p vs. SM22αp); human PASMC in vitro; HIF-1α and Drp1 phosphorylation assays\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific genetic dissection with multiple mouse models and mechanistic pathway validation, multiple orthogonal methods\",\n      \"pmids\": [\"31510791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ALDH2 repression in lung adenocarcinoma leads to acetaldehyde accumulation, which enhances DNA damage and promotes cell migration; ALDH2 knockdown increases and overexpression decreases proliferation, stemness, and migration of lung adenocarcinoma cells; Aldh2-KO mouse lung tissues show increased acetaldehyde and DNA damage in vivo.\",\n      \"method\": \"ALDH2 overexpression and knockdown in lung adenocarcinoma cells; Aldh2-KO mice; Alda-1 treatment; DNA damage assays\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain/loss-of-function in vitro plus in vivo KO validation, single lab\",\n      \"pmids\": [\"31071657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ALDH2 inhibition ablates pathological vascular smooth muscle cell (VSMC) phenotypic switch (contractile to synthetic) through interaction with myocardin; ALDH2 deficiency downregulates miR-31-5p (via increased Max expression), which relieves repression of myocardin mRNA, promoting contractile VSMC phenotype and protecting against aortic aneurysm/dissection.\",\n      \"method\": \"ALDH2 inhibitor treatment in mouse AAD models (BAPN and Ang II); microarray and bioinformatics; gain/loss-of-function for miR-31-5p; primary human VSMC experiments; interaction studies\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mouse models, primary human cells, pathway dissection with multiple methods, single lab\",\n      \"pmids\": [\"32428930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Digenic mutations in ALDH2 (rs671 defective allele) combined with ADH5 mutations cause AMeD syndrome through combined deficiency of formaldehyde clearance, leading to formaldehyde-induced DNA damage that saturates Fanconi anemia repair capacity and impairs hematopoietic stem cell differentiation and proliferation.\",\n      \"method\": \"Patient genetic analysis; cellular studies in patient-derived cells; Adh5/Aldh2 double-knockout mouse model recapitulating AMeD phenotypes\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human patient genetics combined with mouse double-KO model and cellular mechanistic studies, multiple orthogonal methods\",\n      \"pmids\": [\"33355142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ALDH2 overexpression in APP/PS1 Alzheimer's mouse model attenuates cardiac dysfunction by suppressing ferroptosis via the SP1/ACSL4 pathway: ALDH2 reduces lipid peroxidation, decreases ACSL4 and SP1 expression, and prevents ferroptosis; Aβ-induced ferroptosis and cardiomyocyte injury in vitro is rescued by ALDH2 transgene or Alda-1 activator.\",\n      \"method\": \"ALDH2 transgenic crossed with APP/PS1 mice; in vitro Aβ treatment of cardiomyocytes; Alda-1 treatment; SP1 inhibitor (tolfenamic acid) and ACSL4 inhibitor (triacsin C) pharmacological validation\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse model plus in vitro mechanistic validation with pharmacological tools, single lab\",\n      \"pmids\": [\"33767380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Wild-type ALDH2 directly interacts with Rac2 in macrophages and attenuates its K48-linked polyubiquitination at lysine 123, preventing Rac2 degradation; the rs671 mutant ALDH2 destabilizes Rac2, impairing macrophage efferocytosis and accelerating atherosclerosis. Bone marrow transplant experiments confirmed the macrophage-specific role.\",\n      \"method\": \"Bone marrow transplantation (APOE-/-ALDH2-/- to APOE-/-); RNA-seq, proteomics, co-immunoprecipitation; Rac2 ubiquitination assays; human macrophage studies from rs671 carriers\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP with ubiquitination site mapping, bone marrow transplant in vivo, validated in human macrophages from mutation carriers, multiple orthogonal methods\",\n      \"pmids\": [\"35354308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EHMT2 epigenetically represses ALDH2 expression (via H3K9 methylation); NFYA cooperatively regulates ALDH2 transcription; ALDH2 overexpression activates the RAS/RAF oncogenic pathway to confer paclitaxel resistance in non-small cell lung cancer; ALDH2 inhibition or EHMT2 inhibitor restores paclitaxel sensitivity.\",\n      \"method\": \"Gene microarray, cell line and xenograft functional studies, pharmacological ALDH2 inhibition, EHMT2 inhibition with JIB04, clinicopathological patient analysis\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell lines and in vivo xenografts, epigenetic mechanism defined, pathway validated, single lab\",\n      \"pmids\": [\"35477569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ALDH2 deficiency increases autophagy in pulmonary artery smooth muscle cells via the ERK1/2-Beclin-1 pathway, contributing to PASMC migration/proliferation and pulmonary hypertension; ALDH2 knockout in mice exacerbates hypoxia/SU5416-induced PH with increased 4-HNE and autophagosomes.\",\n      \"method\": \"ALDH2 KO mice; lentiviral ALDH2 knockdown in human PASMCs; PDGF-BB stimulation; ERK1/2-Beclin-1 autophagy pathway analysis; electron microscopy; hemodynamic monitoring\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse and cell knockdown with mechanistic pathway analysis, single lab\",\n      \"pmids\": [\"35770049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In zebrafish melanocyte stem cells, Aldh2 activity is required not only for aldehyde clearance but specifically to generate formate (a one-carbon building block for nucleotide biosynthesis) through formaldehyde metabolism, enabling McSC progeny generation during regeneration; disrupting the 1C cycle with methotrexate causes melanocyte regeneration defects; purines are sufficient to rescue Aldh2-deficient McSC regeneration.\",\n      \"method\": \"Live imaging coupled with scRNA-sequencing; aldh2 loss-of-function in zebrafish; metabolic rescue experiments with formate and purines; methotrexate treatment\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with metabolic rescue in vivo, novel mechanistic finding, single lab\",\n      \"pmids\": [\"35485397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"p53 directly binds to ALDH2 and prevents formation of its active tetramer; p53 also indirectly limits pyruvate production (a natural ALDH2 activator), thereby repressing ALDH2 enzymatic activity, reducing acetyl-CoA and histone acetylation, and suppressing SCD1 expression to protect against alcohol-induced fatty liver.\",\n      \"method\": \"Biochemical binding assay (p53-ALDH2 direct interaction); p53-deficient mice with ALDH2 depletion rescue; SCD1 overexpression/knockdown studies; acetyl-CoA and histone acetylation measurements\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct protein-protein interaction demonstrated, genetic rescue experiments in mice, multiple orthogonal biochemical readouts, single lab\",\n      \"pmids\": [\"36825429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ALDH2 directly binds LIN28B (an ELK3 mRNA stability regulator) in endothelial cells, hindering LIN28B binding to ELK3 mRNA and thereby suppressing ELK3 expression; ALDH2-specific knockout in endothelial cells increases ELK3 expression, enhances endothelial barrier integrity via focal adhesion/tight junction upregulation, and suppresses early aortic dilation in AAA.\",\n      \"method\": \"Endothelial cell-specific ALDH2 knockdown/knockout; single-cell RNA sequencing; mRNA sequencing; direct binding study (ALDH2-LIN28B); AAV-mediated ELK3 modulation; Ang II-induced AAA mouse model\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ALDH2-LIN28B interaction demonstrated, cell-type-specific KO with in vivo validation, single lab\",\n      \"pmids\": [\"37822152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ALDH2 alleviates LPS-induced cardiac dysfunction, inflammation, and apoptosis through inhibition of the cGAS/STING signaling pathway; Alda-1 activation of ALDH2 suppresses cGAS/STING while daidzin inhibition exacerbates injury; cGAS siRNA knockdown abolishes the synergistic effect of daidzin, placing ALDH2 upstream of cGAS/STING.\",\n      \"method\": \"LPS-induced mouse and H9C2 cell cardiac injury models; Alda-1 and daidzin pharmacological modulation; cGAS siRNA knockdown; cardiac function by echocardiography; ELISA and flow cytometry\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic epistasis placing ALDH2 upstream of cGAS/STING, multiple readouts, single lab\",\n      \"pmids\": [\"38124089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ALDH2 inhibits myocardial pyroptosis in sepsis by preventing HDAC3 translocation from nucleus to mitochondria, thereby protecting HADHA acetylation; acetylated HADHA supports mitochondrial fatty acid β-oxidation; ALDH2 deficiency allows HDAC3 translocation → HADHA deacetylation → toxic lipid accumulation → mROS and ox-mtDNA release → NLRP3 inflammasome activation and GSDMD-dependent pyroptosis.\",\n      \"method\": \"LPS septic shock mouse model; ALDH2 knockout/knockdown; HDAC3 subcellular fractionation; HADHA acetylation assays; HDAC3 and HADHA siRNA epistasis experiments\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — detailed epistasis with KO and siRNA knockdowns, subcellular fractionation, single lab\",\n      \"pmids\": [\"36992838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CHKB-DT lncRNA physically interacts with ALDH2 mRNA and FUS protein through a GGUG motif, protecting ALDH2 mRNA from degradation; CHKB-DT knockdown aggravates ALDH2 mRNA degradation and 4-HNE production; restoring ALDH2 in CHKB-DT+/- mice rescues cardiac dilation and dysfunction in dilated cardiomyopathy.\",\n      \"method\": \"RNA antisense purification; RNA pull-down; luciferase assay; CRISPR KO mouse model; quantitative proteomics and ribosome profiling; ALDH2 rescue in CHKB-DT+/- mice\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct RNA-protein interaction demonstrated by multiple methods, in vivo genetic rescue, multiple orthogonal approaches in single study\",\n      \"pmids\": [\"38299365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SGLT2 inhibitor empagliflozin ameliorates ALDH2*2-induced endothelial cell dysfunction by inhibiting Na+/H+-exchanger 1 (NHE-1) and activating AKT and eNOS pathways, reducing oxidative stress and restoring NO production; CRISPR-Cas9-corrected ALDH2*2 iPSC-ECs confirm the causal role of ALDH2*2 in EC dysfunction.\",\n      \"method\": \"iPSC-derived ECs from ALDH2*2 carriers; CRISPR-Cas9 correction; empagliflozin treatment; ALDH2*2 knock-in mice; human vasodilation clinical assessment; AKT/eNOS pathway analysis\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isogenic CRISPR correction, multiple model systems (iPSC, mice, human subjects), defined molecular pathway, single rigorous study\",\n      \"pmids\": [\"36696485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ALDH2 activator AD-9308 treatment in Aldh2 wild-type and Glu504Lys knock-in mice reduces 4-HNE-adducted proteins in brown adipose tissue mitochondria; ALDH2 deficiency in BAT leads to 4-HNE adduction of proteins involved in fatty acid oxidation and electron transport chain, decreasing fatty acid oxidation and mitochondrial respiration, impairing adaptive thermogenesis and promoting diet-induced obesity, glucose intolerance, and fatty liver.\",\n      \"method\": \"Aldh2 Glu504Lys knock-in mice; high-fat diet challenge; BAT proteomics (4-HNE-adducted proteins); mitochondrial respiration assays; AD-9308 pharmacological treatment\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — proteomic identification of ALDH2 substrates/targets, physiological knockin model, in vitro mitochondrial assays, pharmacological rescue, single rigorous study\",\n      \"pmids\": [\"37749090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ALDH2 deficiency increases cGAS stability in macrophages by reducing interaction between USP14 (a deubiquitinase) and cGAS; specifically, ALDH2 enzymatic activity reduces 4-HNE accumulation, which decreases USP14-cGAS interaction, allowing K48-linked polyubiquitination degradation of cGAS at lysine 282; ALDH2 deficiency therefore activates cGAS-STING pathway, promoting proinflammatory macrophage polarization and atherosclerosis.\",\n      \"method\": \"ALDH2-KO/ApoE-KO bone marrow transplantation; mechanistic Co-IP and ubiquitination assays; pharmacological cGAS inhibition (RU.521); USP14 knockdown; human macrophages from rs671 carriers\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bone marrow transplant in vivo, direct K48-ubiquitination site mapping, multiple genetic and pharmacological epistasis experiments, validated in human cells\",\n      \"pmids\": [\"39178733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ALDH2 deficiency exacerbates myocardial ischemia/reperfusion injury by promoting neutrophil extracellular trap (NETosis) formation via the endoplasmic reticulum stress/microsomal glutathione S-transferase 2/leukotriene C4 (LTC4)/NOX2 pathway; PAD4 knockout or NETosis-inhibiting drugs (GSK484, DNase1) substantially attenuate myocardial damage in ALDH2 KO mice.\",\n      \"method\": \"ALDH2 KO, PAD4 KO, and ALDH2/PAD4 double KO mice; myocardial I/R model; human STEMI patient cohort (n=308); NETosis pathway mechanistic studies; pranlukast (LTC4 receptor antagonist) treatment\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double KO genetic epistasis, mechanistic pathway defined, validated in human clinical cohort, multiple pharmacological interventions\",\n      \"pmids\": [\"38666340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ALDH2 promotes K48-linked polyubiquitination and degradation of PAD4 by facilitating PAD4 binding to the E3 ubiquitin ligase CHIP, thereby inhibiting NETosis in neutrophils; ALDH2 deficiency reduces PAD4 ubiquitination, increases NETosis, promotes vascular leakage, and exacerbates septic ARDS.\",\n      \"method\": \"Aldh2-KO and Aldh2rs671 knock-in mice; sepsis models; PAD4 ubiquitination assays; CHIP E3 ligase Co-IP; Alda-1 pharmacological rescue; human ARDS patient samples\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct biochemical ubiquitination mechanism with CHIP Co-IP, multiple genetic models (KO + knockin), human patient validation\",\n      \"pmids\": [\"38472357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HSPA8 (Heat Shock 70-kDa Protein 8) translocates to mitochondria under oxygen-glucose deprivation and binds ALDH2, inhibiting its enzymatic activity and promoting fibroblast senescence; siRNA knockdown of HSPA8 increases ALDH2 activity and reduces OGD-induced senescence markers.\",\n      \"method\": \"Co-immunoprecipitation and mass spectrometry identification of ALDH2-HSPA8 interaction; HSPA8 siRNA knockdown; OGD fibroblast model; ALDH2 enzyme activity assays; mitochondrial fractionation\",\n      \"journal\": \"Antioxidants (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP/MS interaction identified, siRNA genetic validation, functional ALDH2 activity readout, single lab\",\n      \"pmids\": [\"38247467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PKCε activation promotes translocation to mitochondria and phosphorylation of ALDH2; activation of the mitochondrial PKCε-ALDH2 axis is required for recovery from 4-HNE-induced mechanical pain hypersensitivity; ALDH2-deficient knockin mice display increased 4-HNE nociceptive behavior and fail to respond to PKCε activator treatment.\",\n      \"method\": \"PKCε knockout mice; ALDH2-deficient knockin mice; PKCε activator peptide (ΨεHSP90); 4-HNE and carrageenan pain models; mechanical hypersensitivity measurements\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double genetic KO/KI epistasis with pharmacological rescue, functional pain readout, single lab\",\n      \"pmids\": [\"34944441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ALDH2 forms homodimers through hydrogen bonding between Glu487 and Arg475 residues; two ALDH2 homodimers form an active tetramer. ALDH2 has dehydrogenase, esterase, and reductase activities with main substrates being aldehydes, 4-nitrophenyl acetate, and nitroglycerin, respectively. Computational modeling predicts that inactive ALDH2*2 mutant subunits can heterotetramerize with ALDH1B1, potentially explaining lack of compensatory ALDH1B1 activity in ALDH2*2 individuals.\",\n      \"method\": \"Structural analysis of ALDH2 homodimerization domains; enzymatic activity characterization; computational molecular modeling of ALDH2-ALDH1B1 heterotetramerization\",\n      \"journal\": \"Nihon eiseigaku zasshi. Japanese journal of hygiene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–3 / Weak — structural/biochemical characterization is established, heterotetramerization is computational prediction only; mixed evidence quality\",\n      \"pmids\": [\"26832618\", \"23247008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Novel non-East Asian ALDH2 missense variants identified in Latino, African, South Asian, and Finnish populations show significantly reduced enzymatic activity in vitro and increased ethanol-induced toxicity in 3T3 cells; a new activator Alda-64 corrects loss of activity in most of these new variants where Alda-1 was ineffective.\",\n      \"method\": \"In vitro enzymatic activity assays; 3T3 cell overexpression of variants; Alda-1 and Alda-64 pharmacological activation screening\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with enzymatic assays and cell-based validation, multiple variants tested, single lab\",\n      \"pmids\": [\"32403082\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ALDH2 is a mitochondrial tetrameric aldehyde dehydrogenase (with dehydrogenase, esterase, and reductase activities) that detoxifies acetaldehyde and reactive lipid aldehydes (notably 4-HNE and malondialdehyde); beyond its canonical metabolic role, it protects genomic integrity by preventing acetaldehyde-DNA adduct formation, regulates multiple signaling pathways (AMPK, cGAS-STING, ERK1/2-Beclin1, PAD4/NETosis, PPARγ/CD36, LKB1-AMPK-SIRT1), is activated by PKCε-mediated phosphorylation, is transcriptionally regulated by the VHL-HNF4α axis and epigenetically by EHMT2/NFYA, is post-translationally inhibited by direct p53 binding that prevents tetramer formation, is protected from mRNA degradation by the lncRNA CHKB-DT, and interacts with Rac2 (stabilizing it against ubiquitin-proteasomal degradation), LIN28B (blocking ELK3 mRNA stabilization), and HSPA8 (which inhibits ALDH2 activity upon mitochondrial translocation); the common ALDH2*2 (Glu504Lys/E487K) dominant-negative variant reduces all these protective functions, increasing susceptibility to alcohol-related cancers, cardiovascular disease, neurodegeneration, and metabolic disorders.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ALDH2 is a mitochondrial tetrameric aldehyde dehydrogenase that detoxifies reactive aldehydes — both ethanol-derived acetaldehyde and the lipid-peroxidation product 4-hydroxynonenal (4-HNE) — and thereby protects genomic integrity, mitochondrial function, and multiple downstream signaling pathways [#2, #5, #27]. The enzyme assembles into an active tetramer of homodimers stabilized by a Glu487-Arg475 hydrogen bond, and carries dehydrogenase, esterase, and reductase activities [#33]. By clearing acetaldehyde, ALDH2 prevents the formation of acetaldehyde-derived DNA adducts; the loss-of-function ALDH2*2 (Glu487Lys/E504K) variant produces an unstable, dominant-negative subunit that allows adduct accumulation, DNA damage, and accelerated carcinogenesis, establishing ALDH2 as a genome-protective tumor suppressor in liver, esophagus, and lung [#0, #1, #3, #4, #13]. By detoxifying 4-HNE, ALDH2 preserves mitochondrial respiration and constrains diverse stress pathways: it restrains cGAS-STING-driven inflammation, ERK1/2-Beclin1 autophagy, PPARγ/CD36 foam-cell formation, SP1/ACSL4 ferroptosis, and PAD4-dependent NETosis, while supporting AMPK and LKB1-AMPK-SIRT1 signaling [#11, #16, #19, #23, #28, #29, #30, #10, #7]. ALDH2 also acts through direct protein interactions independent of bulk aldehyde clearance, stabilizing Rac2 against K48-ubiquitination in macrophages, binding LIN28B to suppress ELK3 in endothelium, and promoting CHIP-mediated PAD4 degradation [#17, #22, #30]. Its activity is tuned by PKCε-mediated phosphorylation, transcriptionally by the VHL-HNF4α axis and EHMT2/NFYA, post-translationally by direct p53 binding that blocks tetramer formation, by mRNA stabilization through the CHKB-DT lncRNA, and by inhibitory mitochondrial HSPA8 binding [#6, #32, #8, #18, #21, #25, #31]. Beyond aldehyde detoxification, Aldh2 also feeds one-carbon metabolism by generating formate for nucleotide biosynthesis during stem-cell regeneration [#20]. Digenic ALDH2/ADH5 deficiency causes AMeD syndrome through failure of formaldehyde clearance [#15].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Established the molecular basis of the East Asian alcohol-flushing phenotype by showing the ALDH2*2 allele produces a catalytically inactive subunit, defining ALDH2 as the dominant acetaldehyde-clearing enzyme in humans.\",\n      \"evidence\": \"Allele-specific oligonucleotide genotyping with phenotypic correlation across populations\",\n      \"pmids\": [\"1733836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how a single substitution destabilizes the protein\", \"No structural or mechanistic basis for the dominant-negative effect at this stage\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected ALDH2 genotype to genotoxicity by demonstrating that deficient individuals accumulate acetaldehyde-derived DNA adducts in vivo, linking the enzyme's metabolic role to genome protection.\",\n      \"evidence\": \"LC/ESI-MS/MS quantification of DNA adducts in genotype-stratified human alcoholics\",\n      \"pmids\": [\"17040107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Correlative in blood DNA, not causal in target tissues\", \"Did not test cancer outcomes directly\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Confirmed in vivo essentiality of ALDH2 for acetaldehyde detoxification using a clean genetic loss-of-function model.\",\n      \"evidence\": \"Aldh2 knockout mice with ethanol feeding and acetaldehyde inhalation; blood acetaldehyde measurement\",\n      \"pmids\": [\"19874182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acute toxicity readout did not address chronic disease or signaling roles\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established ALDH2 as a tumor suppressor that maintains genomic stability, and showed the E487K knockin is dominant-negative through increased protein turnover.\",\n      \"evidence\": \"Endogenous-locus knockin mice with carcinogen treatment, DNA damage assays, and human HCC tissue; KO/KD/OE in esophageal keratinocytes\",\n      \"pmids\": [\"26150517\", \"26374466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which adducts drive transformation not fully resolved\", \"Tissue-specific susceptibility determinants not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined the structural and enzymatic basis of ALDH2 function — tetramer assembly via Glu487-Arg475 and three catalytic activities — and the regulatory PKCε phosphorylation that activates the enzyme.\",\n      \"evidence\": \"Structural/biochemical characterization and computational modeling; siRNA and pharmacological activation in 3T3-L1 preadipocytes\",\n      \"pmids\": [\"26832618\", \"23247008\", \"27575855\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ALDH1B1 heterotetramerization is computational prediction only\", \"No high-resolution structure of the ALDH2*2 tetramer reported here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified upstream transcriptional control of ALDH2 through direct VHL-driven HNF4α activation at the ALDH2 promoter, linking expression to renal cancer drug response.\",\n      \"evidence\": \"Subtractive proteomics, promoter binding assay, RNAi/overexpression, and patient tissue correlation in ccRCC\",\n      \"pmids\": [\"28643803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of this axis beyond renal cells unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked ALDH2 to anti-metastatic signaling by showing its control of acetaldehyde/redox status activates AMPK to suppress HCC migration and invasion.\",\n      \"evidence\": \"Reciprocal gain/loss-of-function in HCC lines and xenografts with AMPK pathway analysis\",\n      \"pmids\": [\"28027570\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanism connecting redox state to AMPK not fully defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended ALDH2's protective role to 4-HNE-driven cardiac pathology, defining the LKB1-AMPK-SIRT1 and mast-cell PKCε-ALDH2 axes in ischemia/reperfusion.\",\n      \"evidence\": \"Ex vivo I/R hearts, KO mice, AAV9 cardiac overexpression, SIRT1 carbonylation and LKB1-AMPK Co-IP\",\n      \"pmids\": [\"29463997\", \"29446730\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab models\", \"Quantitative contribution of each pathway to outcome unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated that 4-HNE accumulation under ALDH2 deficiency drives vascular and metabolic disease through PPARγ/CD36 foam-cell formation, HIF-1α/Drp1 mitochondrial fission, and DNA damage in lung cancer.\",\n      \"evidence\": \"KO macrophages, cell-type-specific AAV overexpression in PASMCs, transgenic/KO mice, and reciprocal manipulation in lung adenocarcinoma cells\",\n      \"pmids\": [\"30853183\", \"31510791\", \"31071657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific specificity of 4-HNE targets only partly mapped\", \"Direct vs indirect effects on each pathway not always separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed non-catalytic and metabolic roles: ALDH2 interacts with the myocardin/miR-31-5p axis in VSMCs, generates formate for one-carbon metabolism in regeneration, and combined ALDH2/ADH5 deficiency causes AMeD syndrome; new disease variants beyond East Asian populations were also catalogued.\",\n      \"evidence\": \"Mouse AAD models and human VSMCs; zebrafish aldh2 loss-of-function with formate/purine rescue; patient genetics and Adh5/Aldh2 double-KO mice; in vitro variant enzymatic assays\",\n      \"pmids\": [\"32428930\", \"35485397\", \"33355142\", \"32403082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of ALDH2-myocardin interaction is Medium-confidence\", \"Relevance of formate generation to mammalian tissues not established here\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established direct protein-stabilization functions: ALDH2 binds Rac2 and protects it from K48-ubiquitination to support macrophage efferocytosis, while epigenetic EHMT2/NFYA control of ALDH2 modulates RAS/RAF-driven chemoresistance, and autophagy is restrained via ERK1/2-Beclin1.\",\n      \"evidence\": \"Bone marrow transplant, Co-IP with ubiquitination site mapping, human carrier macrophages, microarray, and KO mouse PH models\",\n      \"pmids\": [\"35354308\", \"35477569\", \"35770049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Rac2 stabilization is enzymatic-activity-dependent unclear\", \"EHMT2/NFYA findings Medium-confidence\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mapped a multilayered regulatory network: p53 directly blocks ALDH2 tetramerization, CHKB-DT/FUS stabilizes ALDH2 mRNA, HSPA8 inhibits the enzyme in mitochondria, and LIN28B-ELK3 and cGAS-STING/HDAC3-HADHA axes mediate vascular, septic, and inflammatory protection; ALDH2*2 endothelial dysfunction was confirmed in isogenic CRISPR-corrected iPSC-ECs.\",\n      \"evidence\": \"Direct binding assays, genetic rescue mice, RNA pull-down, Co-IP/MS, subcellular fractionation, and CRISPR-corrected iPSC-EC and knockin models\",\n      \"pmids\": [\"36825429\", \"38299365\", \"38247467\", \"37822152\", \"38124089\", \"36992838\", \"36696485\", \"37749090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy and crosstalk among these regulators not integrated\", \"Several downstream signaling links are Medium-confidence single-lab studies\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined ALDH2's control of innate immunity and NETosis: it tunes cGAS stability via 4-HNE/USP14, promotes CHIP-dependent PAD4 degradation, and limits ER-stress/LTC4/NOX2-driven NETosis to protect against atherosclerosis, sepsis-ARDS, and myocardial I/R injury.\",\n      \"evidence\": \"Bone marrow transplant, K48-ubiquitination site mapping, CHIP Co-IP, double-KO (ALDH2/PAD4) epistasis, knockin mice, and human STEMI/ARDS cohorts\",\n      \"pmids\": [\"39178733\", \"38472357\", \"38666340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PAD4/cGAS regulation requires catalytic activity vs scaffolding not fully separated\", \"Integration with the broader regulatory network unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ALDH2's diverse non-catalytic protein-stabilization and signaling functions (Rac2, PAD4, cGAS, LIN28B) are mechanistically partitioned from its enzymatic aldehyde-clearance role, and how its many regulators are coordinated in vivo, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model distinguishing enzymatic vs scaffolding contributions\", \"No high-resolution structural basis for partner interactions\", \"Tissue-specific dominance of competing pathways undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [2, 5, 27, 33]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"GO:0016209\", \"supporting_discovery_ids\": [5, 27]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [17, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [5, 27, 31, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 27]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 3, 4, 15]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [23, 28, 29, 30]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 12, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [16, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"Rac2\", \"LIN28B\", \"HSPA8\", \"PAD4\", \"p53\", \"cGAS\", \"PRKCE\", \"FUS\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}